San Diego-centered Viking Therapeutics marked itself as a significant competitor within the weight loss drug marketplace in February immediately after revealing promising facts from a mid-stage trial of experimental drug VK2735, which prompt it rivaled—and outperformed—Novo and Lilly drugs when presented to be a weekly injection As well as in M